Verrill's patent attorneys specialize in assisting biotech and life science clients at every level from university research, to startups, to mid-market and large corporations. We understand the challenges of leveraging funding for product development from dynamic research programs in a competitive environment. We're experienced in US and foreign patent prosecution, patent litigation, post-grant proceedings, opinions related to non-infringement, invalidity, freedom to operate, inventorship disputes, licensing, portfolio analysis, and competitor analysis.

Our patent prosecutors have extensive experience dealing with patent eligibility matters and work with a wide array of technologies including the following:

  • Antibodies
  • Aptamers
  • Aquaculture
  • Biofuels
  • Cancer therapies and vaccines
  • CAR T-cells
  • Cell culture
  • Chromatography systems
  • CRISPR technology
  • Drug delivery vehicles
  • Drug formulation
  • ELISA
  • Fluorescence in situ hybridization
  • Food science and enzymes
  • Gene therapy
  • Genetic adjuvants
  • Genomics
  • Immunotherapeutics
  • Industrial chemical and biochemical processes
  • Medical diagnostics
  • Microscopy technology and image analysis
  • Modular agricultural systems
  • Nanoparticles
  • Nucleic acids
  • Nutritional biochemistry
  • Probes
  • Proteins
  • Sequencing technology
  • Small molecule pharmaceuticals
  • Spectrometry
  • Stem cells
  • Targeting of drugs and biologics
  • Test kits
  • Transgenic animals
  • Treatment of diabetes and metabolic diseases
  • Viral vectors

Examples of how our patent attorneys have helped their biotech clients include:

  • Quickly established a patent portfolio in the competitive CAR T-cell space to support funding efforts of a biotech startup.
  • Assisted an instrumentation company in an inventorship dispute with its research collaborator, resulting in the company establishing its own patent portfolio.
  • Obtained broad patent coverage for a biologics formulations company to support its partnering efforts.

Firm Highlights

Publication/Podcast

BLM-Masked Employees of Whole Foods Lose Race Bias Appeal Regarding Dress Code

Blog

Charitable Promotions, Commercial Co-Ventures, Donors Choose, Round-Up, and Peer-To-Peer Solicitations

It’s not often that you get BIG news in Charitable Promotions Law. But last year, California passed a comprehensive law that goes into effect on January 1, 2023. So, for all of you brands...

Blog

DOL Proposes Amendments to QPAM Exemption

On July 27, 2022, the Department of Labor (DOL) proposed a set of amendments to Prohibited Transaction Class Exemption 84-14, the so-called “QPAM Exemption,” which permits an investment fund [1] holding assets of ERISA...

News

Verrill Welcomes Back Attorney Stephen B. Segal to Firm’s Litigation & Trial Group

Matter

Elections and Constitutional Law: Successfully Challenged Certification of Initiative Petition

In a victory for consumers and the ride-hailing public, the Massachusetts Supreme Judicial Court recently barred the Secretary of State from placing on the November ballot initiative petitions proposed by companies such as Uber...

Publication/Podcast

Hospitals Win 340B Medicare Rate Cut Suit, But When, How, and How Much They Will Recoup Remains Unclear

In a recent unanimous decision, the Supreme Court found that the Centers for Medicare and Medicaid Services (“CMS”), part of the federal Department of Health and Human Services (“HHS”), erred when it significantly reduced...

Matter

Advised Fortune 500 Company on Group Health and Welfare Benefit Plans

We were engaged by a Fortune 500 manufacturing company to provide legal and compliance services regarding its group health and welfare benefit plans. During the course of our representation, we have advised the company...

News

Verrill Welcomes Attorney Clayton Brite to Firm’s Real Estate Group

Publication/Podcast

New DOJ Task Force Announced Will Impact Health Care Providers & Prescribers in Northern New England

Major enforcement news was released today, Wednesday, June 29, 2022, for medical professionals and anyone working in or around the health care space in Maine , New Hampshire , and Vermont . The United...

Blog

2025 Is the New 2022: IRS Extends Deadline to Adopt SECURE Act Amendments and CARES ACT Waiver of 2020 RMDs Amendment

On August 3, 2022, the IRS released Notice 2022-33 , which extends the deadline for plans to adopt: all SECURE Act [1] amendments, optional or required (a summary of SECURE Act changes can be...

Contact Verrill at (855) 307 0700